Refine
Has Fulltext
- yes (34)
Is part of the Bibliography
- yes (34)
Year of publication
Document Type
- Journal article (30)
- Doctoral Thesis (2)
- Book (1)
- Book article / Book chapter (1)
Keywords
- Psychologie (5)
- bipolar disorder (2)
- water purification (2)
- 1550 nm (1)
- ADHD (1)
- Adsorption (1)
- CBT (1)
- CD117 (1)
- CK5 (1)
- Candida albicans (1)
- Chemie (1)
- DNA-Repair (1)
- Doppler-Verbreiterung (1)
- EGFR (1)
- Eisenoxide (1)
- Entwicklung (1)
- FE (1)
- Ferrite (1)
- GDNF5 (1)
- Gedächtnisbildung (1)
- Gedächtnisleistung (1)
- HEK cells (1)
- HiGHmed (1)
- Jugend (1)
- Kind (1)
- Magnetisches Trennverfahren (1)
- Malignant melanoma (1)
- Materialentwicklung (1)
- Mehrphotonen-Spektroskopie (1)
- MgAl LDH (1)
- Multiple Sklerose (1)
- N ligands (1)
- Nano (1)
- OAT1 (1)
- OAT3 (1)
- OK cells (1)
- Osteoporosis (1)
- Phosphatentfernung (1)
- Photodissoziation (1)
- Photofragmentspektroskopie (1)
- Purin (1)
- Pyrimidinderivate (1)
- Qi gong (1)
- RAD52 (1)
- RET6 (1)
- RNA transport (1)
- RNA-binding proteins (1)
- Recycling (1)
- Resistance training (1)
- Sarcopenia (1)
- Skin cancer screening (1)
- Spinal Orthosis (1)
- Stage distribution (1)
- Superparamagnetismus (1)
- Survival analysis (1)
- TNM staging (1)
- Wasserreinigung (1)
- Wertstoffrückgewinnung (1)
- Whole Body Vibration (1)
- adrenal cortex hormones (1)
- adrenal cortex neoplasms (1)
- adult treatment (1)
- affective consequences (1)
- age (1)
- amination (1)
- articulation (1)
- association (1)
- atom (1)
- at‐risk (1)
- bacterial counts (1)
- behavior (1)
- birth cohort (1)
- blood flow (1)
- branding (1)
- cancer (1)
- case report (1)
- cellular physiology (1)
- childhood asthma (1)
- children (1)
- chromosome 11Q13 (1)
- clinical routine data (1)
- cloning of putative human promoter sequence (1)
- communication (1)
- composite supraparticles (1)
- consumers (1)
- copper (1)
- cortical OAT1 (1)
- depression (1)
- dermatitis (1)
- discoloration index (1)
- doppler broadening (1)
- down regulation (1)
- downconversion (1)
- dye adsorption (1)
- early breast cancer (1)
- early intervention (1)
- early recognition (1)
- efficacy (1)
- electrochemical conversion (1)
- embodiment (1)
- emission (1)
- enteric glial cells (1)
- enteric nervous system (1)
- filaggrin mutations (1)
- fish bone (1)
- fluorinated ligands (1)
- food allergy (1)
- foreign body ingestion (1)
- generation (1)
- genetic phenotypes (1)
- genomewide association (1)
- gingival index (1)
- group treatment (1)
- gut barrier (1)
- hay fever (1)
- heart failure (1)
- heralded entanglement (1)
- human medicine (1)
- illness (1)
- immunodeficiency (1)
- inflammatory bowel disease (1)
- intercellular junctions (1)
- interface (1)
- intestinal epithelial barrier (1)
- intuition (1)
- ischemia (1)
- ischemic acute kidney injury model (1)
- judgements (1)
- juvenile myoclonic epilepsy (1)
- magnetic particles (1)
- magnetic separation (1)
- mapping susceptibility genes (1)
- mass spectrometry (1)
- medical data integration center (1)
- medical informatics initiative (1)
- metabolomics (1)
- moderating role (1)
- molecular neuroscience (1)
- mood disorders (1)
- morality (1)
- mothers (1)
- mouthrinse (1)
- multiphoton spectroscopy (1)
- nano (1)
- nano LDH (1)
- neurotrophic factors (1)
- nitric oxide (1)
- observer agreement (1)
- octenidine (1)
- oncology (1)
- onset (1)
- openEHR (1)
- opossum kidney cells (1)
- parent training (1)
- phasic affective modulation (1)
- phonation (1)
- phonetic symbolism (1)
- photodissociation (1)
- plaque index (1)
- polygenic risk score (1)
- processing fluency (1)
- prodromal (1)
- prognosis (1)
- prophylactic lithium (1)
- prostaglandin e2 (1)
- purine (1)
- pyrimidines (1)
- regulation of expression (1)
- reliability (1)
- reperfusion (1)
- reporter gen assay (1)
- resources recovery (1)
- risk (1)
- risk factors (1)
- risk prediction scores (1)
- semantic coherence (1)
- semantic interoperability (1)
- serious mental illness (1)
- silver (1)
- sound symbolism (1)
- static mixer (1)
- subthreshold bipolar (1)
- superparamagnetism (1)
- surgical management (1)
- synthesis process (1)
- therapy (1)
- thyroid gland (1)
- thyroiditis (1)
- translation (1)
- transport experiments (1)
- triple-negative breast cancer (1)
- up-conversion (1)
- urine (1)
Institute
- Institut für Psychologie (7)
- Institut für Funktionsmaterialien und Biofabrikation (4)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (3)
- Medizinische Klinik und Poliklinik I (3)
- Theodor-Boveri-Institut für Biowissenschaften (3)
- Institut für Klinische Epidemiologie und Biometrie (2)
- Institut für Physikalische und Theoretische Chemie (2)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (2)
- Abteilung für Parodontologie (in der Poliklinik für Zahnerhaltung und Parodontologie) (1)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (1)
Sonstige beteiligte Institutionen
Risk Stratification for Bipolar Disorder Using Polygenic Risk Scores Among Young High-Risk Adults
(2020)
Objective:
Identifying high-risk groups with an increased genetic liability for bipolar disorder (BD) will provide insights into the etiology of BD and contribute to early detection of BD. We used the BD polygenic risk score (PRS) derived from BD genome-wide association studies (GWAS) to explore how such genetic risk manifests in young, high-risk adults. We postulated that BD-PRS would be associated with risk factors for BD.
Methods:
A final sample of 185 young, high-risk German adults (aged 18–35 years) were grouped into three risk groups and compared to a healthy control group (n = 1,100). The risk groups comprised 117 cases with attention deficit hyperactivity disorder (ADHD), 45 with major depressive disorder (MDD), and 23 help-seeking adults with early recognition symptoms [ER: positive family history for BD, (sub)threshold affective symptomatology and/or mood swings, sleeping disorder]. BD-PRS was computed for each participant. Logistic regression models (controlling for sex, age, and the first five ancestry principal components) were used to assess associations of BD-PRS and the high-risk phenotypes.
Results:
We observed an association between BD-PRS and combined risk group status (OR = 1.48, p < 0.001), ADHD diagnosis (OR = 1.32, p = 0.009), MDD diagnosis (OR = 1.96, p < 0.001), and ER group status (OR = 1.7, p = 0.025; not significant after correction for multiple testing) compared to healthy controls.
Conclusions:
In the present study, increased genetic risk for BD was a significant predictor for MDD and ADHD status, but not for ER. These findings support an underlying shared risk for both MDD and BD as well as ADHD and BD. Improving our understanding of the underlying genetic architecture of these phenotypes may aid in early identification and risk stratification.
Molecular-based subclassifications of breast cancer are important for identifying treatment options and stratifying the prognosis in breast cancer. This study aimed to assess the prognosis relative to disease-free survival (DFS) and overall survival (OS) in patients with triple-negative breast cancer (TNBC) and other subtypes, using a biomarker panel including cytokeratin 5 (CK5), cluster of differentiation 117 (CD117), and epidermal growth factor receptor (EGFR). This cohort–case study included histologically confirmed breast carcinomas as cohort arm. From a total of 894 patients, 572 patients with early breast cancer, sufficient clinical data, and archived tumor tissue were included. Using the immunohistochemical markers CK5, CD117, and EGFR, two subgroups were formed: one with all three biomarkers negative (TBN) and one with at least one of those three biomarkers positive (non-TBN). There were significant differences between the two biomarker subgroups (TBN versus non-TBN) in TNBC for DFS (p = 0.04) and OS (p = 0.02), with higher survival rates (DFS and OS) in the non-TBN subgroup. In this study, we found the non-TBN subgroup of TNBC lesions with at least one positive biomarker of CK5, CD117, and/or EGFR, to be associated with longer DFS and OS.
Objectives
To investigate plaque inhibition of 0.1% octenidine mouthwash (OCT) vs. placebo over 5 days in the absence of mechanical plaque control.
Materials and methods
For this randomized, placebo-controlled, double-blind, parallel group, multi-center phase 3 study, 201 healthy adults were recruited. After baseline recording of plaque index (PI) and gingival index (GI), collection of salivary samples, and dental prophylaxis, subjects were randomly assigned to OCT or placebo mouthwash in a 3:1 ratio. Rinsing was performed twice daily for 30 s. Colony forming units in saliva were determined before and after the first rinse. At day 5, PI, GI, and tooth discoloration index (DI) were assessed. Non-parametric van Elteren tests were applied with a significance level of p < 0.05.
Results
Treatment with OCT inhibited plaque formation more than treatment with placebo (PI: 0.36 vs. 1.29; p < 0.0001). OCT reduced GI (0.04 vs. placebo 0.00; p = 0.003) and salivary bacterial counts (2.73 vs. placebo 0.24 lgCFU/ml; p < 0.0001). Tooth discoloration was slightly higher under OCT (DI: 0.25 vs. placebo 0.00; p = 0.0011). Mild tongue staining and dysgeusia occurred.
Conclusions
OCT 0.1% mouthwash inhibits plaque formation over 5 days. It therefore can be recommended when regular oral hygiene is temporarily compromised.
Clinical relevance
When individual plaque control is compromised, rinsing with octenidine mouthwash is recommended to maintain healthy oral conditions while side effects are limited.